Sunresin New Materials Co., Ltd. is proud to announce the creation of Sunresin EU, a new European subsidiary based in Uppsala, Sweden — the historic heart of chromatography and a major life sciences innovation hub.

This strategic expansion marks a significant step in Sunresin’s global growth, strengthening its presence in Europe and reinforcing its commitment to supporting the biopharmaceutical and Life Sciences industries with high-performance resin solutions and advanced application expertise.

Sunresin EU will focus on developing new resins for large-molecule purification and bioprocessing applications, serving the growing markets of monoclonal antibodies and novel therapeutic modalities.

The new facility is strategically located in Uppsala, close to leading universities, research centers, and biotech companies. It will feature state-of-the-art laboratories designed to accelerate innovation, collaboration, and technical development.

By establishing a permanent base in Europe, Sunresin EU brings the company one step closer to its customers, enabling direct technical support, faster delivery of new products, and dedicated space for hands-on application development.

“The creation of Sunresin EU reflects our long-term vision to be at the forefront of resin technology innovation worldwide,” said Dr. Ivy Gao, CEO of Sunresin. “Uppsala’s unique ecosystem makes it the ideal place to strengthen our connection with the European Life Sciences community and to develop next-generation purification technologies.”

The establishment of Sunresin EU is another significant step in the company’s mission to provide the global Life Sciences industry with reliable, efficient, and innovative resin technologies for purification, synthesis, and extraction.

More details about Sunresin EU's leadership and next steps will be shared soon.